2012, ISBN: 9782817803364
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and … Mehr…
Orellfuessli.ch Nr. 34928972. Versandkosten:, Sofort per Download lieferbar, zzgl. Versandkosten, Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage. (EUR 16.66) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), Auflage, [PU: Springer-Verlag], [ED: 1], Springer-Verlag, 2012
lehmanns.de Versandkosten:Download sofort lieferbar. (EUR 29.95) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]
lehmanns.de Versandkosten:Download sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), 2012, [PU: Springer Paris], Springer Paris, 2012
lehmanns.de Versandkosten:Download sofort lieferbar. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, 2012, eBook Download (PDF), eBooks, [PU: Springer Paris]
lehmanns.de Versandkosten:Download sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and … Mehr…
Jean-Louis Prugnaud; Jean-Louis Prugnaud; Jean-Hugues Trouvin; Jean Hugues Trouvin:
Biosimilars - Erstausgabe2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), Auflage, [PU: Springer-Verlag], [ED: 1], Springer-Verlag, 2012
2012
ISBN: 9782817803364
A New Generation of Biologics, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), 2012, [PU: Springer Paris], Springer Paris, 2012
2012, ISBN: 9782817803364
A New Generation of Biologics, 2012, eBook Download (PDF), eBooks, [PU: Springer Paris]
Bibliographische Daten des bestpassenden Buches
Autor: | |
Titel: | |
ISBN-Nummer: |
Detailangaben zum Buch - Biosimilars
EAN (ISBN-13): 9782817803364
ISBN (ISBN-10): 2817803361
Erscheinungsjahr: 2012
Herausgeber: Springer-Verlag
87 Seiten
Sprache: eng/Englisch
Buch in der Datenbank seit 2012-09-27T17:56:33+02:00 (Vienna)
Detailseite zuletzt geändert am 2023-03-01T02:27:40+01:00 (Vienna)
ISBN/EAN: 2817803361
ISBN - alternative Schreibweisen:
2-8178-0336-1, 978-2-8178-0336-4
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: hugues, jean louis lou
Daten vom Verlag:
Autor/in: Jean-Louis Prugnaud; Jean-Hugues Trouvin
Titel: Biosimilars - A New Generation of Biologics
Verlag: Springer; Springer Paris
90 Seiten
Erscheinungsjahr: 2012-11-27
Paris; FR
Gedruckt / Hergestellt in Niederlande.
Sprache: Englisch
117,69 € (DE)
142,00 CHF (CH)
Available
XVIII, 90 p.
EA; E107; eBook; Nonbooks, PBS / Medizin/Klinische Fächer; Onkologie; Verstehen; Biomedicine; Biosimilars; Cost; Immunogenicity; Interchangeability; C; Oncology; Nephrology; Pharmacy; Pharmaceutical Sciences/Technology; Immunology; Oncology; Nephrology; Pharmacy; Pharmaceutics; Immunology; Medicine; Nierenheilkunde, Nephrologie; Pharmazie, Apotheke; Medizinische Chemie, Pharmazeutische Chemie; Immunologie; BB
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Neuestes ähnliches Buch:
9782817805146 Biosimilars (Jean-Louis Prugnaud; Jean-Hugues Trouvin)
< zum Archiv...